Stockholders’ Equity (Details) - USD ($) |
1 Months Ended | 3 Months Ended | 12 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
Sep. 13, 2022 |
Jul. 11, 2022 |
Dec. 31, 2019 |
Dec. 30, 2022 |
Aug. 30, 2022 |
Aug. 30, 2022 |
Feb. 23, 2021 |
Mar. 31, 2023 |
Mar. 31, 2022 |
Dec. 31, 2022 |
Feb. 16, 2021 |
|
| Stockholders' Equity (Textual) | |||||||||||
| Common Stock, Shares Authorized | 750,000,000 | 750,000,000 | |||||||||
| Common Stock, Par or Stated Value Per Share (in Dollars per share) | $ 0.0001 | $ 0.0001 | |||||||||
| Common Stock, Shares, Issued | 376,901,679 | 376,901,679 | |||||||||
| Common Stock, Shares, Outstanding | 376,901,679 | 376,901,679 | |||||||||
| Other Tax Expense (Benefit) (in Dollars) | $ 0 | $ 62,766 | |||||||||
| Preferred stock, authorized | 25,000,000 | 25,000,000 | |||||||||
| Preferred stock, par value (in Dollars per share) | $ 0.0001 | $ 0.0001 | |||||||||
| Description of compensation service | (i) a cash endorsement fee of Three Hundred Thousand U.S. Dollars ($300,000 USD), payable as follows: (i) One Hundred Twenty-Five Thousand Dollars ($125,000) upon execution of the Endorsement Agreement, (ii) One Hundred Twenty-Five Thousand Dollars ($125,000) quarterly during the Term, beginning on the 90th day following the Effective Date, and (iii) Fifty Thousand Dollars ($50,000) on or prior to the first anniversary of the Effective Date and (ii) warrants exercisable for an aggregate of Fifteen Million (15,000,000) shares of the Common Stock at an exercise price of $0.0345 per share. The Warrants shall have a three-year term commencing from the Effective Date. | ||||||||||
| Shares of Common Stock | 2,500 | 51,901,711 | |||||||||
| Expiration Date | Aug. 30, 2027 | ||||||||||
| Purchased shares | 2,250,000 | ||||||||||
| Exercise price (in Dollars per share) | $ 0.04 | ||||||||||
| Note amendment transaction description | the Company entered into the December 2022 Note Amendment Transaction, as fully described in note 9 above. In terms of the Note Amendment Transaction the following occurred: ● The warrants issued to Cavalry and Mercer exercisable for 4,973,914 shares of common stock (2,486,957 for each of Cavalry and Mercer), were exchanged for two promissory notes of $482,000 each, as disclosed in note 8 above; ● The warrants issued to Cavalry and Mercer on August 30, 2022, were subject to repricing and a full rachet increase in the number of warrants issued, resulting in an increase in the number of warrants by 72,260,870 (36,130,435 to each Cavalry and Mercer) and a reset of the exercise price to $0.0115 per share. The additional warrants were valued at $841,003 using a Black-Scholes valuation model and was expensed in the statement of operations as a component of the loss on convertible debt. ● An additional 13,736,857 warrants previously issued to Mercer, Iroquois Master Fund and Bellridge Capital LP were subject to repricing of the exercise price from a range of $0.05 to $0.15 per share to $0.0115 per share. The change in the fair value of these warrants of $20,079, using a Black-Scholes valuation model was recorded as a component of the loss on convertible debt. | ||||||||||
| Limitation exceeds percentage | 9.99% | ||||||||||
| Warrants outstanding an intrinsic value (in Dollars) | $ 0 | 0 | |||||||||
| Incentive stock options | 201,112,800 | ||||||||||
| Amount of immediate expense (in Dollars) | $ 31,970 | ||||||||||
| Options exercisable shares | 200,000 | ||||||||||
| Intrinsic value outstanding options (in Dollars) | $ 0 | 0 | |||||||||
| Option expense (in Dollars) | $ 94,464 | $ 94,466 | |||||||||
| Common Stock [Member] | |||||||||||
| Stockholders' Equity (Textual) | |||||||||||
| Shares of Common Stock | 3,000,000 | 3,000,000 | |||||||||
| Exercise price (in Dollars per share) | $ 0.15 | ||||||||||
| Exercise price (in Dollars per share) | $ 0.0115 | ||||||||||
| Options exercisable shares | 800,000 | ||||||||||
| Warrant [Member] | |||||||||||
| Stockholders' Equity (Textual) | |||||||||||
| Purchased shares | 30,000,000 | ||||||||||
| Fair value of warrants (in Dollars) | $ 348,938 | ||||||||||
| Maximum [Member] | |||||||||||
| Stockholders' Equity (Textual) | |||||||||||
| Shares of Common Stock | 800,000 | ||||||||||
| Maximum [Member] | Common Stock [Member] | |||||||||||
| Stockholders' Equity (Textual) | |||||||||||
| Shares of Common Stock | 100,000 | ||||||||||
| Maximum [Member] | |||||||||||
| Stockholders' Equity (Textual) | |||||||||||
| Warrants beneficially percentage | 4.99% | ||||||||||
| Chief Executive Officer [Member] | |||||||||||
| Stockholders' Equity (Textual) | |||||||||||
| Incentive stock options | 15,000,000 | ||||||||||
| Stock option exercise price (in Dollars per share) | $ 0.15 | ||||||||||
| Amount of immediate expense (in Dollars) | $ 823,854 | ||||||||||
| Debt Conversion Notices [Member] | |||||||||||
| Stockholders' Equity (Textual) | |||||||||||
| Aggregate shares of common stock | 46,521,739 | ||||||||||
| Convertible debt amount (in Dollars) | $ 0.0115 | ||||||||||
| 2021 Stock Incentive Plan [Member] | Maximum [Member] | |||||||||||
| Stockholders' Equity (Textual) | |||||||||||
| Shares of Common Stock | 53,000,000 | ||||||||||
| 2018 Stock Incentive Plan [Member] | |||||||||||
| Stockholders' Equity (Textual) | |||||||||||
| Terminates period | 10 years | ||||||||||
| 2021 Stock Incentive Plan [Member] | |||||||||||
| Stockholders' Equity (Textual) | |||||||||||
| Terminates period | 10 years | ||||||||||